139 related articles for article (PubMed ID: 30592555)
1. Reducing proteolytic liability of a MMP-14 inhibitory antibody by site-saturation mutagenesis.
Lee KB; Dunn Z; Ge X
Protein Sci; 2019 Mar; 28(3):643-653. PubMed ID: 30592555
[TBL] [Abstract][Full Text] [Related]
2. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
[TBL] [Abstract][Full Text] [Related]
3. Epitope-specific affinity maturation improved stability of potent protease inhibitory antibodies.
Lopez T; Chuan C; Ramirez A; Chen KE; Lorenson MY; Benitez C; Mustafa Z; Pham H; Sanchez R; Walker AM; Ge X
Biotechnol Bioeng; 2018 Nov; 115(11):2673-2682. PubMed ID: 30102763
[TBL] [Abstract][Full Text] [Related]
4. Protease Inhibition Mechanism of Camelid-like Synthetic Human Antibodies.
Nam DH; Lee KB; Kruchowy E; Pham H; Ge X
Biochemistry; 2020 Oct; 59(40):3802-3812. PubMed ID: 32997500
[TBL] [Abstract][Full Text] [Related]
5. Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries.
Nam DH; Rodriguez C; Remacle AG; Strongin AY; Ge X
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):14970-14975. PubMed ID: 27965386
[TBL] [Abstract][Full Text] [Related]
6. Identification of highly selective MMP-14 inhibitory Fabs by deep sequencing.
Lopez T; Nam DH; Kaihara E; Mustafa Z; Ge X
Biotechnol Bioeng; 2017 Jun; 114(6):1140-1150. PubMed ID: 28090632
[TBL] [Abstract][Full Text] [Related]
7. Selectivity Conversion of Protease Inhibitory Antibodies.
Lopez T; Ramirez A; Benitez C; Mustafa Z; Pham H; Sanchez R; Ge X
Antib Ther; 2018 Sep; 1(2):55-63. PubMed ID: 30406213
[No Abstract] [Full Text] [Related]
8. Functional selection of protease inhibitory antibodies.
Lopez T; Mustafa Z; Chen C; Lee KB; Ramirez A; Benitez C; Luo X; Ji RR; Ge X
Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16314-16319. PubMed ID: 31363054
[TBL] [Abstract][Full Text] [Related]
9. Generation of Highly Selective MMP Antibody Inhibitors.
Nam DH; Ge X
Methods Mol Biol; 2018; 1731():307-324. PubMed ID: 29318563
[TBL] [Abstract][Full Text] [Related]
10. Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase.
Mendes DE; Wong-On-Wing A; Berkman CE
J Enzyme Inhib Med Chem; 2016; 31(1):167-71. PubMed ID: 25815671
[TBL] [Abstract][Full Text] [Related]
11. Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein.
Nestorowicz A; Chambers TJ; Rice CM
Virology; 1994 Feb; 199(1):114-23. PubMed ID: 8116234
[TBL] [Abstract][Full Text] [Related]
12. Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization.
Nam DH; Fang K; Rodriguez C; Lopez T; Ge X
Protein Eng Des Sel; 2017 Feb; 30(2):113-118. PubMed ID: 27986919
[TBL] [Abstract][Full Text] [Related]
13. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
[TBL] [Abstract][Full Text] [Related]
14. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
15. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
16. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
Beyer BB; Johnson JV; Chung AY; Li T; Madabushi A; Agbandje-McKenna M; McKenna R; Dame JB; Dunn BM
Biochemistry; 2005 Feb; 44(6):1768-79. PubMed ID: 15697202
[TBL] [Abstract][Full Text] [Related]
17. Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody.
Udi Y; Grossman M; Solomonov I; Dym O; Rozenberg H; Moreno V; Cuniasse P; Dive V; Arroyo AG; Sagi I
Structure; 2015 Jan; 23(1):104-115. PubMed ID: 25482542
[TBL] [Abstract][Full Text] [Related]
18. Determination of the P1', P2' and P3' subsite-specificity of factor Xa.
Ludeman JP; Pike RN; Bromfield KM; Duggan PJ; Cianci J; Le Bonniec B; Whisstock JC; Bottomley SP
Int J Biochem Cell Biol; 2003 Feb; 35(2):221-5. PubMed ID: 12479872
[TBL] [Abstract][Full Text] [Related]
19. Pericellular proteolysis by matrix metalloproteinase-7 is differentially modulated by cholesterol sulfate, sulfatide, and cardiolipin.
Yamamoto K; Miyazaki K; Higashi S
FEBS J; 2014 Aug; 281(15):3346-56. PubMed ID: 24903600
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors.
Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX
Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
